Quantity: ~1M viable cells
CIRM Line ID: CW20090
Disease: Autism Spectrum Disorder
Gender: Female
Sampled age: 18
Ethinicity: Asian


Quantity: ~1M viable cells

CIRM Line ID: CW20090

Disease: Autism Spectrum Disorder

Gender: Female

Sampled age: 18

Race: Asian

Donor data

Demographic (source: CIRM) Description AUTISM SPECTRUM DISORDER; ASD
Affected Status Yes
Product iPSC
Source PBMC
Sex Female
Age at Sampling 18 YR
Race Asian
Ethnicity Not Hispanic or Latino
Publications Cited 0
dbGap No
Diagnosis Age 3
Biopsy Source Blood
Collection Neurodevelopmental Disorders
Cell Type Stem Cell
Tissue Type Induced pluripotent stem cell
Transformant Episomal
Species sapiens
Common Name human
Detailed Clinical Data false
Clinical data (source: CIRM) ASD ASD
Number_of_siblings_with_ASD 0
Symptoms_Present_in_the_First_Year_of_Life No data
Communication_-_Verbal 20
Communication_-_Nonverbal 12
Restricted_Repetitive_and_Stereotyped_Patterns_of_ 6
Abnormality_of_Development_Evident_at_or_Before_36 4
Qualitative_Impairment_in_Reciprocal_Social_Intera 29
ADOS_Test_Used ADOS 2
Communication_and_Social 13
Stereotyped_Behaviors_and_Restricted_Interests 5
Full_Scale_IQ 40
Verbal_IQ 43
Non_Verbal_IQ 40
Test_used Stanford Binet
ASDMedicalFamilyHistory ASDMedicalFamilyHistory
Diagnosis Autism Spectrum Disorder
Birthweight_(kgs) 3.88
Birth_order 2
Number_of_siblings_(includes_half_and_whole_siblin 1
Weight_% 50
Height_% 55.88
Head_Circumference_(cm) 59
Maternal_age_(years) 54
Maternal_age_at_delivery_(years) 36
Paternal_age_(years) 59
Paternal_age_at_delivery_(years) 41
Chromosome_test_results Not Available
Consanguinity No
  • Users do not need any additional license for the use of these differentiated cells even when cells are used for high throughput screening or drug discovery.
  • All donor consents include statements on the following:
    • Testing the cells’ DNA (this is referred to as the cell’s genetic code or sequence) and making the information known to other researchers
    • Changing some of the genetic code or sequence within these cells
    • Using cells to test or select drugs to treat disease
    • Transplanting cells or resulting products to humans or animals

      Distributing cells widely (nationally and internationally) for research, training or commercial medical product development

    • Future research and uses unforeseen at this time
  • Donors were screened and negative for HIV, HBV, and HCV. Donors under the age of 18 could opt out of HIV testing; all HCV-positive donors submitted skin punches, not peripheral blood, and were not screened for any infectious agents due to small volume of blood present in punches.
  • Human induced pluripotent stem cells were established by non-integrating episomal reprogramming. Reprogramming and quality control were performed by Cellular Dynamics International.


Please refer this page for some characteristics data.